type 1 diabetes

Type 1 diabetes is a chronic condition affecting millions worldwide, typically diagnosed in childhood or adolescence. It occurs when the body's immune system mistakenly attacks and destroys the insulin-producing cells in the pancreas, leading to little or no insulin production. Insulin is a vital hormone that regulates blood sugar levels. Recent developments mark a significant breakthrough in managing this disease. A new drug, the first of its kind to delay the onset of type 1 diabetes, has been approved for use on the NHS in England and Wales. This represents the most substantial advancement in tackling the condition in over a century. Furthermore, the NHS is expanding the use of artificial pancreas systems, also known as hybrid closed-loop systems. These advanced technologies, combining continuous glucose monitors and algorithms, are helping to reduce disparities in diabetes care, particularly among different ethnic and socioeconomic groups. These advancements highlight a renewed focus on improving both the prevention and management of type 1 diabetes.